Insider Shareholders with Direct Ownership of Cortexyme, Inc. (CRTX)
This section provides a comprehensive overview of the insiders with direct ownership of Cortexyme, Inc. (CRTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Cortexyme, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Pfizer Inc
> 10% Shareholder |
3,249,973 | 370,000 | 2,879,973 $3.72 Million | 2 |
Jun 03, 2020
Reduced 11.38%
|
| 8,295 | 0 | 2,834,561 $3.66 Million | 3 |
Aug 21, 2019
Added 0.06%
|
|
|
Dirk Thye
CEO AND CHIEF MEDICAL OFFICER |
627,619 | 0 | 843,941 $1.09 Million | 6 |
Aug 30, 2024
Added 8.36%
|
|
Philip S Low
Director |
455,309 | 0 | 455,309 $587,348 | 1 |
May 19, 2022
Added 50.0%
|
|
Brendan Hannah
CHIEF BUSINESS OFFICER AND COO |
182,971 | 0 | 296,540 $382,536 | 6 |
Aug 21, 2024
Added 7.36%
|
|
Christopher P. Lowe
Interim CEO, COO & CFO |
311,963 | 46,963 | 265,000 $341,850 | 10 |
Mar 03, 2022
Added 39.77%
|
|
Leslie Holsinger
EVP, Preclinical Development |
199,000 | 50,920 | 148,080 $191,023 | 5 |
Jun 06, 2022
Reduced 6.87%
|
|
Michael J. Detke
Chief Medical Officer |
180,000 | 68,261 | 140,000 $180,600 | 7 |
Mar 03, 2022
Added 50.0%
|
|
Caryn Gordon Mc Dowell
Chief Legal & Adm. Officer |
140,000 | 17,500 | 122,500 $158,025 | 2 |
Jun 06, 2022
Reduced 8.1%
|
|
Charles S. Ryan
PRESIDENT |
48,387 | 0 | 122,461 $157,974 | 1 |
Aug 20, 2024
Added 28.32%
|
|
Casey Lynch
Chief Executive Officer |
60,000 | 0 | 109,895 $141,764 | 1 |
Nov 18, 2021
Added 35.32%
|
|
Ted Monohon
Chief Accounting Officer & VP |
34,000 | 6,560 | 27,440 $35,397 | 5 |
Mar 06, 2023
Reduced 6.38%
|
| 22,327 | 0 | 27,000 $34,830 | 1 |
Jun 08, 2022
Added 50.0%
|
|
|
Karen L. Smith
Chief Medical Officer |
24,336 | 0 | 24,336 $31,393 | 1 |
May 19, 2022
Added 50.0%
|
| 15,000 | 7,550 | 8,000 $10,320 | 6 |
Aug 08, 2023
Added 50.0%
|